- Home
- AEHL vs QNRX Comparison
AEHL vs QNRX Comparison
Compare AEHL & QNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AEHL
- QNRX
- Stock Information
- Founded
- AEHL 1993
- QNRX 2018
- Country
- AEHL China
- QNRX United States
- Employees
- AEHL N/A
- QNRX N/A
- Industry
- AEHL Building Materials
- QNRX Medical/Dental Instruments
- Sector
- AEHL Industrials
- QNRX Health Care
- Exchange
- AEHL Nasdaq
- QNRX Nasdaq
- Market Cap
- AEHL 2.9M
- QNRX 3.3M
- IPO Year
- AEHL 2007
- QNRX N/A
- Fundamental
- Price
- AEHL $2.82
- QNRX $7.70
- Analyst Decision
- AEHL
- QNRX
- Analyst Count
- AEHL 0
- QNRX 0
- Target Price
- AEHL N/A
- QNRX N/A
- AVG Volume (30 Days)
- AEHL 282.8K
- QNRX 528.4K
- Earning Date
- AEHL 05-01-2025
- QNRX 05-13-2025
- Dividend Yield
- AEHL N/A
- QNRX N/A
- EPS Growth
- AEHL N/A
- QNRX N/A
- EPS
- AEHL N/A
- QNRX N/A
- Revenue
- AEHL $98,773,000.00
- QNRX N/A
- Revenue This Year
- AEHL N/A
- QNRX N/A
- Revenue Next Year
- AEHL N/A
- QNRX N/A
- P/E Ratio
- AEHL N/A
- QNRX N/A
- Revenue Growth
- AEHL 36.99
- QNRX N/A
- 52 Week Low
- AEHL $2.00
- QNRX $5.01
- 52 Week High
- AEHL $256.40
- QNRX $54.95
- Technical
- Relative Strength Index (RSI)
- AEHL 48.79
- QNRX 58.05
- Support Level
- AEHL $2.47
- QNRX $6.21
- Resistance Level
- AEHL $2.87
- QNRX $9.63
- Average True Range (ATR)
- AEHL 0.30
- QNRX 0.80
- MACD
- AEHL 0.07
- QNRX 0.29
- Stochastic Oscillator
- AEHL 88.14
- QNRX 46.83
About AEHL Antelope Enterprise Holdings Limited
Antelope Enterprise Holdings Ltd is a manufacturer of ceramic tiles in China. Its ceramic tiles are used for exterior siding, interior flooring, and design in residential and commercial buildings. The company's products are Porcelain, Glazed, Glazed porcelain, Rustic, and polished glazed tiles. The Company operates in the manufacturing and sale of medium to high-end ceramic tiles and providing business management consulting, information system technology consulting services including the sales of software use rights for digital data deposit platforms and asset management systems, and online social media platform development and consulting.
About QNRX Quoin Pharmaceuticals Ltd.
Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.